文献速递毛发、甲与色素性疾病自身免疫性与大疱性皮肤病银屑病与炎症性皮肤病

COVID-19后自身免疫与自身炎症性结缔组织病的长期风险

Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19.
PubMed 文献 · JAMA Dermatol · 2024-01-01

COVID-19组多种自身免疫与自身炎症性结缔组织病风险升高,包括斑秃、白癜风、白塞病、类风湿关节炎、系统性红斑狼疮、舍格伦综合征、大疱性类天疱疮等。重症 COVID-19、Delta 流行期和未接种疫苗与更高风险相关。

要点

  • COVID-19后斑秃、白癜风、白塞病及大疱性类天疱疮等风险升高。
  • 重症需ICU、Delta期及未接种疫苗者风险更高。
  • 建议对COVID-19康复者结合人口学、病情严重度与接种状态长期随访。

核心结论

  • COVID-19与多种自身免疫及自身炎症性结缔组织病的长期风险升高相关。
  • 应结合人口学因素、疾病严重程度和疫苗接种状态进行长期监测与照护。

研究设计与样本

  • 韩国疾病管理厅-国民健康保险服务K-COV-N队列的全国性回顾性人群研究。
  • 共6 912 427人(53.6%男性;平均[SD]年龄53.39[20.13]岁),COVID-19组3 145 388人、对照组3 767 039人,观察期超180天。
  • 采用逆概率加权平衡人口学、健康数据、社会经济状态和合并症等协变量。

主要发现

  • 斑秃AHR 1.11(95% CI 1.07-1.15),全秃AHR 1.24(95% CI 1.09-1.42)。
  • 白癜风AHR 1.11(95% CI 1.04-1.19),白塞病AHR 1.45(95% CI 1.20-1.74)。
  • 克罗恩病AHR 1.35(95% CI 1.14-1.60),溃疡性结肠炎AHR 1.15(95% CI 1.04-1.28)。
  • 类风湿关节炎AHR 1.09(95% CI 1.06-1.12),系统性红斑狼疮AHR 1.14(95% CI 1.01-1.28)。
  • 舍格伦综合征AHR 1.13(95% CI 1.03-1.25),强直性脊柱炎AHR 1.11(95% CI 1.02-1.20),大疱性类天疱疮AHR 1.62(95% CI 1.07-2.45)。

关键数值与推荐

  • 亚组分析显示男性与女性、年龄小于40岁和40岁及以上与不同自身免疫结局风险存在多样化关联。
  • 重症COVID-19需ICU入住、Delta流行期和未接种疫苗与更高风险相关。

临床怎么用

  • 对COVID-19康复者应结合人口学特征、疾病严重程度和疫苗接种状态进行长期随访。
  • 皮肤科接诊新发斑秃、白癜风、大疱性类天疱疮等患者时,可将近期COVID-19史纳入病史评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Few studies have investigated the association between COVID-19 and autoimmune and autoinflammatory connective tissue disorders; however, research with long-term observation remains insufficient. OBJECTIVE: To investigate the long-term risk of autoimmune and autoinflammatory diseases after COVID-19 over an extended observation period. DESIGN, SETTING, AND PARTICIPANTS: This retrospective nationwide population-based study investigated the Korea Disease Control and Prevention Agency-COVID-19-National Health Insurance Service (K-COV-N) cohort. Individuals with confirmed COVID-19 from October 8, 2020, to December 31, 2022, and controls identified among individuals who participated in the general health examination in 2018 were included in the analysis. EXPOSURES: Confirmed COVID-19. MAIN OUTCOMES AND MEASURES: Incidence and risk of autoimmune and autoinflammatory connective tissue disorders in patients after COVID-19. Various covariates, such as demographic characteristics, general health data, socioeconomic status, and comorbidity profiles, were balanced using inverse probability weighting. RESULTS: A total of 6 912 427 participants (53.6% male; mean [SD] age, 53.39 [20.13] years) consisting of 3 145 388 with COVID-19 and 3 767 039 controls with an observational period of more than 180 days were included. Alopecia areata (adjusted hazard ratio [AHR], 1.11 [95% CI, 1.07-1.15]), alopecia totalis (AHR, 1.24 [95% CI, 1.09-1.42]), vitiligo (AHR, 1.11 [95% CI, 1.04-1.19]), Behçet disease (AHR, 1.45 [95% CI, 1.20-1.74]), Crohn disease (AHR, 1.35 [95% CI, 1.14-1.60]), ulcerative colitis (AHR, 1.15 [95% CI, 1.04-1.28]), rheumatoid arthritis (AHR, 1.09 [95% CI, 1.06-1.12]), systemic lupus erythematosus (AHR, 1.14 [95% CI, 1.01-1.28]), Sjögren syndrome (AHR, 1.13 [95% CI, 1.03-1.25]), ankylosing spondylitis (AHR, 1.11 [95% CI, 1.02-1.20]), and bullous pemphigoid (AHR, 1.62 [95% CI, 1.07-2.45]) were associated with higher risk in the COVID-19 group. Subgroup analyses revealed that demographic factors, including male and female sex, age younger than 40 years, and age 40 years and older, exhibited diverse associations with the risk of autoimmune and autoinflammatory outcomes. In addition, severe COVID-19 infection requiring intensive care unit admission, the Delta period, and not being vaccinated were associated with higher risk. CONCLUSIONS AND RELEVANCE: This retrospective cohort study with an extended follow-up period found associations between COVID-19 and the long-term risk of various autoimmune and autoinflammatory connective tissue disorders. Long-term monitoring and care of patients is crucial after COVID-19, considering demographic factors, disease severity, and vaccination status, to mitigate these risks.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Heo YW, Jeon JJ, Ha MC, et al. Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19. JAMA Dermatol. 2024. PMID: 39504045. doi:10.1001/jamadermatol.2024.4233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。